PGP and neoplasm: By silencing P-gp and thereby reducing the cells' drug efflux capacity, TDRN@DOX@AuNCp significantly enhances the intracellular retention of DOX, overcoming MDR mechanisms and resulting in potent anti-tumor effects (Figure 9G) 169.